Lindgren Arne G
Department of Neurology, Skåne University Hospital; Department of Clinical Sciences Lund, Neurology, Lund University, Lund, Sweden.
J Cereb Blood Flow Metab. 2025 Apr 11:271678X251332528. doi: 10.1177/0271678X251332528.
The understanding of genomics has improved tremendously during the last decades. The concept of recovery and outcome after stroke has also progressed during this time. However, the connection between genomics and stroke recovery has only begun to emerge in a more structural and comprehensive way. Different types of outcomes and recovery occur after stroke. This depends on domain of neurological deficit, severity, resilience, receptivity for rehabilitation measures, and concomitant morbidity. Methods for assessing stroke patients' prognosis depend on these factors. Different genetic approaches are possible and there is an increasing need for linking genetic findings to other omics as well as to clinically meaningful results. This review addresses recent advances and views in clinical genomics of stroke recovery and outcome in humans with focus on current and previous studies, concepts, and future perspectives.
在过去几十年中,人们对基因组学的理解有了极大的提高。在此期间,中风后恢复和预后的概念也取得了进展。然而,基因组学与中风恢复之间的联系才刚刚开始以一种更具结构性和全面性的方式显现出来。中风后会出现不同类型的结果和恢复情况。这取决于神经功能缺损的领域、严重程度、恢复力、对康复措施的接受程度以及伴随的发病率。评估中风患者预后的方法取决于这些因素。不同的基因方法是可行的,并且越来越需要将基因研究结果与其他组学以及具有临床意义的结果联系起来。本综述重点关注当前和以往的研究、概念及未来展望,阐述了人类中风恢复和预后临床基因组学的最新进展和观点。